HomeHome SearchSearch MenuMenu Our productsOur products Who we areWho we are

Metastatic non-small cell lung cancer patients may benefit from combined therapy

by , 28 September 2017
Metastatic non-small cell lung cancer patients may benefit from combined therapy
Approximately every one in four cancer deaths are from lung cancer, making it the leading cause of cancer death among men and women by far. But it's not all doom and gloom…

A breakthrough study has determined that combining radiation with chemotherapy for limited metastatic non-small cell lung cancer patients may slow down the progression of the disease. Keep reading for the full findings.

Study finds that combined therapy can help slow down the progression of lung cancer

The study was carried out by researchers from the University of Texas Southwestern Medical Center in the United States and published in the journal JAMA Oncology.
 
To reach their findings, the researchers accrued 29 patints between April 2015 and July 2016. Their study uncovered that progression-free lung cancer survival escalated from three-and-a-half months to just under 10 months by adding radiation to chemotherapy to all the metastatic sites of lung cancer, as well as the primary disease site.

***

Did you know, cannabis can be GOOD for your health?

 

No. I’m not suggesting you start smoking dagga!

 

I want to introduce you to the powerful healing properties of a very special oil, which although it does come from the cannabis plant, is completely legal and will NOT make you high. Instead, research shows this special oil can help treat everything from cancer, to seizures, to heart conditions, to anxiety and various skin conditions.

 

Curious? Click here to find out about nature’s best-kept secret for yourself.

 

*** 
 

Lead author of the study shares his thoughts on these ground-breaking findings…

“Even in the era of immunotherapy, there are not large numbers of metastatic NSCLC patients with durable responses to systemic therapy,” said Puneeth Iyengar, lead author of the study and an assistant professor or radiation oncology at the University of Texas Southwestern Medical Center.
 
“In our trial, however, the addition of radiation therapy directed at each of the cancerous areas greatly improved how patients responded to subsequent rounds of chemotherapy. This finding suggests that local treatments, including radiation, could work in concert with chemotherapy to prolong the amount of time before recurrence occurs in patients with limited sites of metastatic non-small cell lung cancer,” Iyengar added.

Vote article

Metastatic non-small cell lung cancer patients may benefit from combined therapy
Rating:
Note: 5 of 1 vote

Related articles





Related articles


FEATURED



Health Solutions

Resources